Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
Shares of Philip Morris ( NYSE: PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...
The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
FDA decision makes ZYN the first authorized ... 21+ Access Only Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI's U.S. affiliates are committed to responsible ...
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International ... than a decade as FDA reviewed company ...